本页面由Tiger Trade Technology Pte. Ltd.提供服务

Phathom Pharmaceuticals

7.07
-0.0650-0.91%
成交量:92.41万
成交额:650.04万
市值:5.72亿
市盈率:-5.58
高:7.16
开:7.14
低:6.86
收:7.13
52周最高:18.31
52周最低:6.52
股本:8,090.09万
流通股本:6,392.64万
量比:0.73
换手率:1.45%
股息:- -
股息率:- -
每股收益(TTM):-1.2659
每股收益(LYR):-3.0342
净资产收益率:-3489.00%
总资产收益率:-8.80%
市净率:-1.66
市盈率(LYR):-2.33

数据加载中...

2024/07/18

重要事件披露

Form 8-K - Current report
2024/06/15

SEC问询函

Form CORRESP - Correspondence
2024/06/14

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/06/14

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/06/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/07

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/15

重要事件披露

Form 8-K - Current report
2023/12/14

重要事件披露

Form 8-K - Current report
2023/12/06

重要事件披露

Form 8-K - Current report